Proteomics International Laboratories Ltd (ASX:PIQ) has published groundbreaking results demonstrating the unique OxiDx test for oxidative stress can identify muscle damage and assess recovery in elite marathon runners.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce the publication of new results in the journal Human Reproduction showing its PromarkerEndo blood test can diagnose all stages of endometriosis with high accuracy.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its cash reserves have been further strengthened by the receipt of $2.16 million in research and development tax incentive for the 2023-24 financial year.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe today to attendees of the Bell Potter Healthcare Conference 2024.
TruScreen Group Limited (NZE:TRU) (ASX:TRU) is pleased to provide an update of its key markets and target markets.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman's Address to be provided by Mr Neville Gardiner and the Investor Presentation to be provided by Dr Richard Lipscombe to shareholders.
Proteomics International Laboratories Ltd (ASX:PIQ) today announces the appointment of Aaron Brinkworth to its Board as independent, non-executive Director, in concert with the retirement of Roger Moore as non-executive Director.
